Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Glenmark

Glenmark gets USFDA nod for expanded use of RYALTRIS nasal spray

Glenmark Pharmaceuticals announced US FDA approval for RYALTRIS nasal spray. This approval expands its use to children aged six to twelve years. The nasal spray treats symptoms of seasonal allergic rhinitis effectively. RYALTRIS combines antihistamine and corticosteroid in one formulation. This marks a significant step in expanding access to the…

The Economic Times

Stocks in news: Adani Enterprises, Cochin Shipyard, IDFC First Bank, Premier Energies, Glenmark Pharma

Markets traded subdued on the weekly expiry day, with indices ending marginally lower. Cochin Shipyard's offer for sale saw strong investor demand on its first day. Adani Enterprises' US legal case faces a likely dismissal by federal prosecutors. IDFC First Bank launched provident fund payment services through its EPFO integration.…

The Economic Times

FDA Recalls Potassium Chloride Capsules Due To Dissolution Issue

FDA recalls potassium chloride capsules from Glenmark Pharmaceuticals and American Health Packaging due to failed dissolution, posing heart attack risks.

Top News

From analysis to the latest developments in health,
read the most diverse news in one place.

Health secretary accused of failing to act on shortages of motor neurone disease drug

Exclusive: Shortages of riluzole, which can delay the onset of ventilator dependence, were flagged to DHSC in September

The Guardian - UK

Whatever happened to the case of 66 child deaths linked to cough syrup from India?

Since the deaths in The Gambia, there have been additional charges that medicines made in India were contaminated and led to sickness. What has happened to the companies involved?

WEKU

Indian study reveals about 3% of drugs ‘substandard’ amid official crackdown

In wake of children’s cough syrup scandal, an expert says regulatory system is ‘grossly understaffed and underfunctional’

The Guardian - UK

Coronavirus: First nasal spray to treat COVID patients in India launched

Mumbai based pharma company Glenmark has launched the Nitric Oxide Nasal Spray under the brand name FabiSpray for the treatment of adult patients with Covid-19 infection. The nasal spray has been launched in partnership with Canadian pharmaceutical company SaNOtize.

The Times of India

Read news from The Economist, FT, and more,
with one subscription

People

Victoria Atkins

193 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the Department of Health

110 stories

The Department of Health and Social Care

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.